Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLXPF | AMGN | VRTX | REGN | BMY |
| Company | Cybin Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.0500 | 324.13 | 483.39 | 710.01 | 60.95 |
| High | 3.2000 | 335.88 | 503.89 | 748.29 | 63.16 |
| Low | 2.8736 | 322.77 | 480.38 | 709.38 | 60.72 |
| Last | 3.0200 | 327.36 | 500.01 | 744.83 | 63.11 |
| Change | -0.0400 | +2.50 | +11.72 | +37.32 | +2.02 |
| % Change | -1.31% | +0.77% | +2.40% | +5.27% | +3.31% |
| Volume | 864,300 | 4,120,700 | 1,796,700 | 1,631,700 | 20,295,701 |
| 20-Day Average Volume | 1,094,590 | 3,086,835 | 1,371,225 | 905,150 | 12,528,990 |
| Previous Close | 3.0600 | 324.86 | 488.29 | 707.51 | 61.09 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.8482 | 305.89 | 476.45 | 693.65 | 57.70 |
| 20-Day Raw Stochastic | 71.64% | 82.07% | 93.30% | 96.26% | 99.48% |
| 20-Day Relative Strength | 62.45% | 70.78% | 64.97% | 59.11% | 66.91% |
| Weighted Alpha | +130.72 | +21.61 | +22.10 | -25.59 | +31.15 |
| Today's Opinion | N/A | 24% Buy | 40% Buy | 56% Sell | 100% Buy |
| Previous Opinion | N/A | 24% Buy | 40% Buy | 56% Sell | 88% Buy |
| Last Month's Opinion | N/A | 24% Sell | 8% Sell | 64% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.46% since 07/28/21 | +5.33% since 03/03/25 | +3.46% since 03/03/25 | +8.75% since 03/03/25 | +5.41% since 03/03/25 |
| Low | 2.7300 on 07/29/21 | 310.14 on 03/05/25 | 479.78 on 03/06/25 | 672.50 on 03/04/25 | 59.03 on 03/06/25 |
| High | 3.3800 on 08/02/21 | 335.88 on 03/10/25 | 503.89 on 03/10/25 | 748.29 on 03/10/25 | 63.16 on 03/10/25 |
| 1-Month | |||||
| %Chg | +42.45% since 07/02/21 | +11.05% since 02/10/25 | +6.39% since 02/10/25 | +7.89% since 02/10/25 | +13.65% since 02/10/25 |
| Low | 2.1105 on 07/08/21 | 288.36 on 02/11/25 | 446.00 on 02/12/25 | 655.85 on 02/12/25 | 53.54 on 02/18/25 |
| High | 3.3800 on 08/02/21 | 335.88 on 03/10/25 | 503.89 on 03/10/25 | 748.29 on 03/10/25 | 63.16 on 03/10/25 |
| 3-Month | |||||
| %Chg | +79.76% since 05/04/21 | +18.72% since 12/10/24 | +6.56% since 12/10/24 | -4.32% since 12/10/24 | +8.59% since 12/10/24 |
| Low | 1.3429 on 06/01/21 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 642.00 on 02/04/25 | 53.54 on 02/18/25 |
| High | 3.3800 on 08/02/21 | 335.88 on 03/10/25 | 503.89 on 03/10/25 | 781.32 on 12/11/24 | 63.16 on 03/10/25 |
| 6-Month | |||||
| %Chg | +76.61% since 02/04/21 | -0.48% since 09/10/24 | +6.21% since 09/10/24 | -34.45% since 09/10/24 | +28.06% since 09/10/24 |
| Low | 0.9500 on 03/30/21 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 642.00 on 02/04/25 | 47.76 on 09/12/24 |
| High | 3.3800 on 08/02/21 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 1,170.58 on 09/13/24 | 63.16 on 03/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 453,224 | 175,859,424 | 128,397,568 | 81,428,536 | 128,069,880 |
| Shares Outstanding, K | 148,598 | 537,205 | 256,790 | 109,325 | 2,029,312 |
| Annual Sales | 650,000 | 33,424,000,000 | 11,020,100,000 | 14,202,000,000 | 48,300,000,000 |
| Annual Net Income | -24,420,000 | 4,090,000,000 | -535,600,000 | 4,412,600,000 | -8,948,000,000 |
| Last Quarter Sales | N/A | 9,086,000,000 | 2,912,000,000 | 3,789,200,000 | 12,342,000,000 |
| Last Quarter Net Income | N/A | 627,000,000 | 913,000,000 | 917,700,000 | 72,000,000 |
| 60-Month Beta | N/A | 0.53 | 0.41 | 0.27 | 0.43 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.31 on 02/04/25 | 3.98 on 02/10/25 | 12.07 on 02/04/25 | 1.67 on 02/06/25 |
| Latest Earnings Date | N/A | 05/01/25 | 05/05/25 | 05/01/25 | 04/24/25 |
| Most Recent Dividend | N/A | 2.380 on 02/14/25 | N/A | 0.880 on 02/20/25 | 0.620 on 01/03/25 |
| Next Ex-Dividends Date | N/A | 05/16/25 | N/A | 02/20/25 | 04/04/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.39 | 0.00 | 17.82 | 53.59 |